[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
[ Fri, Jul 30th 2021 ]: WOPRAI
David Lebovitz Maintained (BPMC) at Hold with Decreased Target to $96 on, Jul 30th, 2021
- 🞛 This publication is a summary or evaluation of another publication
David Lebovitz of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Decreased Target from $101 to $96 on, Jul 30th, 2021.
David has made no other calls on BPMC in the last 4 months.
There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brad Canino of "Credit Suisse" Initiated at Hold and Held Target at $100 on, Wednesday, March 31st, 2021
These are the ratings of the 4 analyists that currently disagree with David
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $137 on, Thursday, June 17th, 2021
- Joel Beatty of "Baird" Maintained at Buy with Increased Target to $123 on, Thursday, June 17th, 2021
- Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $130 on, Thursday, June 17th, 2021
- Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Decreased Target to $110 on, Thursday, April 29th, 2021